Navigation Links
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
Date:9/24/2007

ng otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's intentions, beliefs, expectations and strategies for the future, including those relating to product performance and usage in the clinical diagnostics market, potential size of certain clinical diagnostics markets and future products for the clinical market. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: unforeseen development and manufacturing problems; our ability to successfully obtain regulatory approvals for additional products and to introduce new products in the clinical market; customer market acceptance of new products; the failure of products to perform as expected, whether due to manufacturing errors, defects or otherwise; the impact of competitive products and pricing; the impact of vaccinations in the target market; potentially lengthy sales cycles in some markets; reimbursement rates for the products; and underlying market co
'/>"/>

SOURCE Cepheid
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. WARF enters licensing agreements for stem cell products
2. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
3. Software company enters health space with RFID solutions on hold
4. Lucigen Corp. enters global licensing agreement
5. Call centers and customer service: The good, the bad, and the clueless
6. GE Healthcare enters agreement with Canadian health authority
7. Data centers: Buyers beware of over-hyped facilities
8. Data centers: Blowing smoke and raising red flags
9. Prodesse enters patent agreement with Roche
10. UW-Madison enters Kauffman grant competition
11. Applied Technology Centers to aid printing and manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics).  Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...
(Date:6/18/2013)... 18, 2013 As a leading ... proudly announces the release of their infographic - ... ". , MeMD's goal was to leverage an ... Health 2.0, Health 3.0 and mHealth.The infographic features ... medical care and the fitness industry in unimaginable ...
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Kitware ... today announces a new Fast-Track award from the U.S. ... design-analysis environment (IDAE) for the nuclear power industry. , ... for more than 30 years, but the United States’ ... remarkable gains in power plant utilization through improved refueling, ...
Breaking Biology Technology:Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2
... announced today that the company is proceeding with ... of its heparin sodium injection,multi-dose, single-dose vials and ... recalled nine lots of heparin sodium injection,multi-dose vials ... due to a,higher than usual number of reports ...
... Exclusion Order Barring Importation of CryoCath,s Cryoablation System, ... (Nasdaq:,CRYO), a medical device company focused on the ... filed a formal complaint with the,United States International ... engaged in unfair trade practices by infringing on,several ...
... 28 InterMune, Inc.,(Nasdaq: ITMN ) today ... of InterMune, will present at Susquehanna,s Second Annual,SIGnificant ... March 5, 2008,at 2:30 p.m. EST., To ... investors and other,interested parties may log on to ...
Cached Biology Technology:Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 2Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 3CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 3InterMune to Present at the SIGnificant Options in Healthcare Conference 2
(Date:6/18/2013)... lab. At Brandeis University, sophisticated computational models and ... understand the complex interplay between genomic data, virus ... "shell" critical for replication. , ... finding will help researchers alter virus assembly, leaving ... Perlmutter, first author of the scientific paper describing ...
(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious ... 2013 ICAAC Young Investigator Award for his research on ... to infection. , Obar earned his B.A. in ... on to complete his Ph.D. in Microbiology and Immunology ... Ph.D. thesis research in Edward Usherwood,s laboratory at the ...
(Date:6/18/2013)... a chemical modification of DNA and this modification ... DNA sequence. Until now, scientists believed that this ... genes. Today, a team of researchers from the ... Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, ... and that DNA methylation may play both a ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... cell surface protein inhibited prostate cancer growth and metastasis ... not respond to hormone therapy, according to a study ... UCLA,s Jonsson Comprehensive Cancer Center. The researchers also ... turned on in prostate cancer that does not respond ...
... biologist Jonathan Brody, Ph.D., assistant professor, Department of ... professor, and member of the Daniel Baugh Institute ... Pathology, Anatomy and Cell Biology at Jefferson Medical ... a W.W. Smith Charitable Trust medical research grant. ...
... "metabolomics" profile of smokers immediately after they had ... cell death, inflammation, and other forms of systemic ... Center, part of Georgetown University Medical Center. ... Ninth AACR Frontiers in Cancer Prevention Research Meeting, ...
Cached Biology News:UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 2UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 3Jefferson researchers receive W.W. Smith Charitable Trust 2Jefferson researchers receive W.W. Smith Charitable Trust 3Studying the metabolome of smokers, Lombardi researchers find early signs of damage 2
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Human Cell Line Slides...
Human Cell Line Slides...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
Biology Products: